PLASMA CONCENTRATIONS AND BIOAVAILABILITY OF CLOFIBRATE AFTER ADMINISTRATION TO HUMAN SUBJECTS

被引:18
作者
CHASSEAUD, LF [1 ]
COOPER, AJ [1 ]
SAGGERS, VH [1 ]
机构
[1] HUNTINGDON RES CTR, DEPT METAB & PHARMACOKINETICS, HUNTINGDON PE18 6ES, ENGLAND
关键词
D O I
10.1002/j.1552-4604.1974.tb01415.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:382 / 386
页数:5
相关论文
共 22 条
[1]  
BARR W H, 1969, Drug Information Bulletin, V3, P27
[3]   REDUCTION OF SERUM TRIGLYCERIDES AND CHOLESTEROL BY ETHYL P-CHLOROPHENOXY-ISOBUTYRATE ( CPIB ) [J].
BEST, MM ;
DUNCAN, CH .
AMERICAN JOURNAL OF CARDIOLOGY, 1965, 15 (02) :230-&
[4]  
CHASSEAUD LF, IN PRESS
[5]  
FLORENCE AT, 1972, PHARM J, V20, P456
[6]  
GELBER R, 1969, CLIN PHARMACOL THER, V10, P841
[7]  
GRUNDY SM, 1972, J LIPID RES, V13, P531
[8]   LONG-TERM EFFECTS OF CLOFIBRATE (ATROMID-S) ON SERUM LIPIDS IN MAN [J].
HUNNINGHAKE, DB ;
TUCKER, DR ;
AZARNOFF, DL .
CIRCULATION, 1969, 39 (05) :675-+
[9]  
LEVY RI, 1969, ADV EXP MED BIOL, V4, P377
[10]   VARIATION IN BIOLOGIC AVAILABILITY OF DIGOXIN FROM 4 PREPARATIONS [J].
LINDENBAUM, J ;
MELLOW, MH ;
BLACKSTONE, MO ;
BUTLER, VP .
NEW ENGLAND JOURNAL OF MEDICINE, 1971, 285 (24) :1344-+